MetLife Investment Management’s Curis CRIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-25
Closed -$24.1K 2870
2022
Q1
$24.1K Sell
25
-57
-70% -$72.8K ﹤0.01% 2703
2021
Q4
$156K Buy
82
+23
+39% +$54.7K ﹤0.01% 2209
2021
Q3
$185K Sell
59
-24
-29% -$75K ﹤0.01% 2149
2021
Q2
$269K Buy
+83
New +$375K ﹤0.01% 1957

Other funds holding CRIS

MetLife Investment Management's CRIS Position: Q2 2022 in Review

MetLife Investment Management sold out of Curis (CRIS) in Q2 2022, closing a stake of 25 shares — an estimated $24.1K sold.

MetLife Investment Management first reported a position in CRIS in Q2 2021 and held it in 4 quarters. The position peaked at $269K in Q2 2021. 86 funds tracked by Wall St. Rank hold CRIS as of Q2 2022.

  • MetLife Investment Management reported no remaining Curis position as of Q2 2022 after selling out during the quarter.
  • MetLife Investment Management sold 25 Curis shares in Q2 2022, an estimated $24.1K.
  • MetLife Investment Management first reported a position in Curis in Q2 2021 and held it in 4 quarters.
  • MetLife Investment Management's Curis position peaked at $269K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held Curis as of Q2 2022.

Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.